Novel treatment options for juvenile idiopathic arthritis

Katherine A. Steigerwald, Norman Todd Ilowite

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The purpose of this review is to summarize the newer and possible future treatments for the arthritis and systemic features in children with juvenile idiopathic arthritis (JIA), including evidence supporting their efficacy and safety.

Original languageEnglish (US)
Pages (from-to)559-573
Number of pages15
JournalExpert Review of Clinical Pharmacology
Volume8
Issue number5
DOIs
StatePublished - Sep 3 2015

Fingerprint

Juvenile Arthritis
Arthritis
Safety
Therapeutics

Keywords

  • Biologics
  • Juvenile idiopathic arthritis
  • Novel
  • Small molecules
  • Treatment

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Novel treatment options for juvenile idiopathic arthritis. / Steigerwald, Katherine A.; Ilowite, Norman Todd.

In: Expert Review of Clinical Pharmacology, Vol. 8, No. 5, 03.09.2015, p. 559-573.

Research output: Contribution to journalArticle

@article{b76fe74fc12a46de9de869909b1a7b9f,
title = "Novel treatment options for juvenile idiopathic arthritis",
abstract = "The purpose of this review is to summarize the newer and possible future treatments for the arthritis and systemic features in children with juvenile idiopathic arthritis (JIA), including evidence supporting their efficacy and safety.",
keywords = "Biologics, Juvenile idiopathic arthritis, Novel, Small molecules, Treatment",
author = "Steigerwald, {Katherine A.} and Ilowite, {Norman Todd}",
year = "2015",
month = "9",
day = "3",
doi = "10.1586/17512433.2015.1061428",
language = "English (US)",
volume = "8",
pages = "559--573",
journal = "Expert Review of Clinical Pharmacology",
issn = "1751-2433",
publisher = "Expert Reviews Ltd.",
number = "5",

}

TY - JOUR

T1 - Novel treatment options for juvenile idiopathic arthritis

AU - Steigerwald, Katherine A.

AU - Ilowite, Norman Todd

PY - 2015/9/3

Y1 - 2015/9/3

N2 - The purpose of this review is to summarize the newer and possible future treatments for the arthritis and systemic features in children with juvenile idiopathic arthritis (JIA), including evidence supporting their efficacy and safety.

AB - The purpose of this review is to summarize the newer and possible future treatments for the arthritis and systemic features in children with juvenile idiopathic arthritis (JIA), including evidence supporting their efficacy and safety.

KW - Biologics

KW - Juvenile idiopathic arthritis

KW - Novel

KW - Small molecules

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=84939785375&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939785375&partnerID=8YFLogxK

U2 - 10.1586/17512433.2015.1061428

DO - 10.1586/17512433.2015.1061428

M3 - Article

VL - 8

SP - 559

EP - 573

JO - Expert Review of Clinical Pharmacology

JF - Expert Review of Clinical Pharmacology

SN - 1751-2433

IS - 5

ER -